Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Omeros Corporation Stock Is Skyrocketing Today


Shares of Omeros Corporation (NASDAQ: OMER) skyrocketed 40.5% higher as of 11:12 a.m. ET on Monday. The huge gain came after the company announced that Rayner Surgical paid a $200 million milestone payment. This payment is related to Omeros' sale of its ophthalmology product Omidria to Rayner in December 2021.

Omeros received an upfront payment of $125 million with the sale of Omidria. However, the agreement included a commercial milestone payment of $200 million. That commercial milestone was met in late December 2022.

Omeros had around $195 million available to fund its operations at the end of 2022. The $200 million payment from Rayner puts the company in a much stronger financial position. Omeros chairman and CEO Gregory Demopulos said that the milestone payment should fund operations "well into at least 2025."

Continue reading


Source Fool.com

Like: 0
Share

Comments